We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$364M
2
SIVB
SVB Financial Group
SIVB
+$155M
3
TXT icon
Textron
TXT
+$103M
4
TWTR
Twitter, Inc.
TWTR
+$102M
5
SNY icon
Sanofi
SNY
+$96.4M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLMA icon
876
Olema Pharmaceuticals
OLMA
$985M
$2.04M ﹤0.01%
500,000
+411,203
+463% +$1.3M
CRBU icon
877
Caribou Biosciences
CRBU
$149M
$2.02M ﹤0.01%
372,033
-237,034
-39% -$1.81M
UHS icon
878
Universal Health Services
UHS
$10.2B
$2.01M ﹤0.01%
19,959
-56,400
-74% -$7.06M
PUMP icon
879
ProPetro Holding
PUMP
$1.37B
$2M ﹤0.01%
200,000
-595,380
-75% -$7.83M
CFRX
880
DELISTED
ContraFect Corporation
CFRX
$2M ﹤0.01%
8,125
– –
NWS icon
881
News Corp Class B
NWS
$17.2B
$1.99M ﹤0.01%
125,334
-4,400
-3% -$81.9K
ICVX
882
DELISTED
Icosavax, Inc. Common Stock
ICVX
$1.83M ﹤0.01%
320,000
-85,130
-21% -$664K
SYRS
883
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.83M ﹤0.01%
190,000
– –
SYF icon
884
Synchrony
SYF
$25.3B
$1.83M ﹤0.01%
66,187
+7,900
+14% +$274K
VIRX
885
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.82M ﹤0.01%
470,000
+216,309
+85% +$616K
ALGS icon
886
Aligos Therapeutics
ALGS
$28.5M
$1.78M ﹤0.01%
58,931
– –
TCRX icon
887
TScan Therapeutics
TCRX
$47.3M
$1.73M ﹤0.01%
550,000
– –
ITT icon
888
ITT
ITT
$17.7B
$1.71M ﹤0.01%
25,366
-10,000
-28% -$712K
ABEO icon
889
Abeona Therapeutics
ABEO
$364M
$1.67M ﹤0.01%
320,291
– –
VAPO
890
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.65M ﹤0.01%
81,250
+25,000
+44% +$915K
VAXX
891
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$1.57M ﹤0.01%
1,001,670
– –
JBIO
892
Jade Biosciences
JBIO
$1.17B
$1.56M ﹤0.01%
2,857
– –
MDVL
893
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1.53M ﹤0.01%
20,000
– –
IRON icon
894
Disc Medicine
IRON
$2.93B
$1.49M ﹤0.01%
29,420
– –
TUEM
895
DELISTED
Tuesday Morning Corp
TUEM
$1.49M ﹤0.01%
137,950
– –
CBAY
896
DELISTED
Cymabay Therapeutics
CBAY
$1.48M ﹤0.01%
500,000
-1,000,000
-67% -$2.39M
CNTB
897
Connect Biopharma Holdings
CNTB
$124M
$1.46M ﹤0.01%
1,677,519
+240,019
+17% +$353K
IDYA icon
898
IDEAYA Biosciences
IDYA
$3.41B
$1.44M ﹤0.01%
104,401
-88,900
-46% -$989K
TDUP icon
899
ThredUp
TDUP
$801M
$1.44M ﹤0.01%
573,844
– –
STEM icon
900
Stem
STEM
$50.3M
$1.43M ﹤0.01%
10,000
+5,000
+100% +$831K
34 35
36
37 38

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.